Cargando…
The Impact of Post-Analytical Tools on New York Screening for Krabbe Disease and Pompe Disease
New York uses a two-tier assay to screen newborns for Krabbe disease and Pompe disease. Individual enzyme activities are measured in the first-tier, and specimens from newborns with low activity are reflexed to second tier Sanger sequencing of the associated gene. Using only this two-tiered approach...
Autores principales: | Martin, Monica M., Wilson, Ryan, Caggana, Michele, Orsini, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569953/ https://www.ncbi.nlm.nih.gov/pubmed/33239591 http://dx.doi.org/10.3390/ijns6030065 |
Ejemplares similares
-
Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
por: Kwon, Jennifer M., et al.
Publicado: (2018) -
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease
por: Herbst, Zackary, et al.
Publicado: (2020) -
Neuroimmune mechanisms in Krabbe's disease
por: Potter, Gregory B., et al.
Publicado: (2016) -
Two-Tiered Newborn Screening with Post-Analytical Tools for Pompe Disease and Mucopolysaccharidosis Type I Results in Performance Improvement and Future Direction
por: Hall, Patricia L., et al.
Publicado: (2020) -
Low Psychosine in Krabbe Disease with Onset in Late Infancy: A Case Report
por: Corre, Camille S., et al.
Publicado: (2021)